FBTAX Mutual Fund (Fidelity Advisor Biotechnology Fund Class A) is managed by Fidelity Investments (US) with $779.2M in net assets. FBTAX expense ratio is 0.96%, holding 92 positions across sectors including Health Care, Financials, Unknown. Inception date: 2000-12-27.

FBTAX performance shows a YTD return of 5.71%. The 1-year return is 58.43% and the 5-year return is 10.32%. FBTAX dividend yield stands at 1.14%, paid semi-annually.

FBTAX top holdings include Abbvie Inc (16.6%), Gilead Sciences Inc (6.6%), Alnylam Pharmace (5.0%), Ascendis Pharma As Adr (4.5%), Cogent Biosciences Inc (3.8%). View all FBTAX holdings, sector breakdown, or dividend history.

FBTAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTAX alternatives are available via the screener, along with tax-loss harvesting opportunities.